本頁面由Tiger Trade Technology Pte. Ltd.提供服務

CRISPR Therapeutics AG

39.10
+0.17000.44%
盤後:39.500.4000+1.02%19:57 EST
成交量:332.25萬
成交額:1.31億
市值:37.81億
市盈率:-8.22
高:40.17
開:38.18
低:38.15
收:38.93
52周最高:63.45
52周最低:38.15
股本:9,669.26萬
流通股本:9,420.30萬
量比:1.01
換手率:3.53%
股息:- -
股息率:- -
每股收益(TTM):-4.7595
每股收益(LYR):-6.4700
淨資產收益率:-25.60%
總資產收益率:-13.49%
市淨率:2.29
市盈率(LYR):-6.04

資料載入中...

2026/11/17

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/11/13

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/11/10

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/11/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/11/02

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/11/02

重要事件披露

Form 8-K - Current report
2026/10/19

重要事件披露

Form 8-K - Current report
2026/10/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/10/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/09/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/03

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/03

重要事件披露

Form 8-K - Current report
2026/07/28

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/06/05

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/06/04

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/14

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/04

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]